PICO Portalanswers from OpenAlex & ORCID
Soonmo Peter Kang
ResearcherPublications, citations & collaboration network
Soonmo Peter Kang is a researcher indexed in PICO Portal from OpenAlex & ORCID.
How many works does Soonmo Peter Kang have?
PICO Portalindexed works
Soonmo Peter Kang has 94 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Soonmo Peter Kang have?
PICO Portalcitation count
Soonmo Peter Kang has 18,214 citations in the OpenAlex counts PICO Portal stores.
What is the h-index of Soonmo Peter Kang?
PICO Portalh-index
Soonmo Peter Kang has an h-index of 36 in OpenAlex.
What is the i10-index of Soonmo Peter Kang?
PICO Portali10-index
Soonmo Peter Kang has an i10-index of 66 in OpenAlex.
What is the OpenAlex record for Soonmo Peter Kang?
PICO Portalopenalex
The OpenAlex for Soonmo Peter Kang is on the source record.
What are the most-cited papers on Soonmo Peter Kang?
PICO Portalmost cited works
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le, Jennifer N. Durham, Kellie N. Smith, Hao Wang, Bjarne R. Bartlett, Laveet K. Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon Luber, Fay Wong, Nilofer S. Azad, Agnieszka A. Rucki, Dan Laheru, Ross C. Donehower, Atif Zaheer, George A. Fisher, Todd S. Crocenzi, James J. Lee, Tim F. Greten, Austin G. Duffy, Kristen K. Ciombor, Aleksandra Eyring, Bao H. Lam, Andrew K. Joe, Soonmo Peter Kang, Matthias Holdhoff, Ludmila Danilova, Leslie Cope, Christian F. Meyer, Shibin Zhou, Richard M. Goldberg, Deborah K. Armstrong, Katherine M. Bever, Amanda N. Fader, Janis M. Taube, Franck Housseau, David Spetzler, Nianqing Xiao, Drew M. Pardoll, Nickolas Papadopoulos, Kenneth W. Kinzler, James R. Eshleman, Bert Vogelstein, Robert A. Anders, Luis A. Díaz
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
Takashi Kojima, Manish A. Shah, Kei Muro, Éric François, Antoine Adenis, Chih‐Hung Hsu, Toshihiko Doi, Toshikazu Moriwaki, Sung‐Bae Kim, Se‐Hoon Lee, Jaafar Bennouna, Ken Kato, Lin Shen, Peter C. Enzinger, Shukui Qin, Paula Ferreira, Jia Chen, Gustavo Girotto, Christelle de la Fouchardière, Hélène Senellart, Raed Moh’d Taiseer Al-Rajabi, Florian Lordick, Ruixue Wang, Shailaja Suryawanshi, Pooja Bhagia, Soonmo Peter Kang, Jean‐Philippe Metges, on behalf of the KEYNOTE-181 Investigators
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus
Manish A. Shah, Takashi Kojima, Daniel Hochhauser, Peter C. Enzinger, Judith Raimbourg, Antoine Hollebecque, Florian Lordick, Sung‐Bae Kim, Masahiro Tajika, Heung Tae Kim, A. Craig Lockhart, Hendrik-Tobias Arkenau, Farid El-Hajbi, Mukul Gupta, Per Pfeiffer, Qi Liu, Jared Lunceford, Soonmo Peter Kang, Pooja Bhagia, Ken Kato